Loading the security page…
A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Drugs Made In America Acquisition II Corp. (DMII) is a company in the Financials sector; its shares trade on Nasdaq.
The price of Drugs Made In America Acquisition II Corp. (DMII) on November 10, 2026 is 10.23 $, 0.00 % on the day. Over 52 weeks the stock traded between 9.86 $ and 10.33 $; the price now sits 79 % of the way up that range. The P/E ratio is 10.77, which is below the sector median (13.01). Market capitalization is 140.15 million $, rank 92 among 203 stocks of the same industry with a known capitalization.
Drugs Made In America Acquisition II Corp. trades on Nasdaq under the ticker DMII. The company belongs to the Financials sector. The trading history on this page starts on 3 December 2025.
Over the past 52 weeks DMII has traded between 9.86 $ and 10.33 $. As of 10 November 2026 the price stood 78.74% of the way from the 52-week low to the high.
DMII trades at a price-to-earnings ratio of 10.8, below the sector median of 13.0. Calculated from reports for the period ending 30 June 2026.